Best Online GLP-1 Programs

How we rank the best online GLP-1 providers

To compare these online GLP-1 providers we look at five things a reader actually cares about: whether prescribing is handled by US-licensed clinicians, the range of products offered (compounded vs. brand-name, injectable vs. oral), transparent starting prices, the speed and cost of shipping, and whether the program locks you into a membership. The ordering reflects our overall read on value and experience — it is not medical advice or a clinical ranking. Talk to a licensed provider before starting any GLP-1 medication.

What is a GLP-1, and how does it work?

GLP-1 medications are a class of drugs called GLP-1 receptor agonists. They copy a natural gut hormone, glucagon-like peptide-1, that your body releases after you eat. By activating the GLP-1 receptor they do three things: they prompt the pancreas to release insulin only when blood sugar is high, they slow how fast the stomach empties, and they act on appetite centers in the brain to increase fullness and reduce hunger. That combination is why people eat less and lose weight on these drugs.^[1]

Not every drug in this guide is the same molecule. Semaglutide (the active ingredient in Ozempic and Wegovy) is a single GLP-1 receptor agonist.^[2] Tirzepatide (the active ingredient in Mounjaro and Zepbound) is a dual GIP and GLP-1 receptor agonist, meaning it activates a second gut-hormone receptor as well, which is the main reason its trial weight-loss numbers run higher than semaglutide's.^[3]

Who qualifies for an online GLP-1 program?

For weight management, the FDA-approved GLP-1 drugs follow the same general eligibility rule used in their labels: a body mass index (BMI) of 30 or higher, or a BMI of 27 or higher together with at least one weight-related health condition such as high blood pressure, type 2 diabetes, high cholesterol, or obstructive sleep apnea.^[4][5] Obesity is defined clinically as a BMI of 30 or above.^[8]

Online programs screen for this during the intake questionnaire or video visit. A licensed clinician makes the final call on whether a GLP-1 is appropriate for you, so meeting the BMI numbers does not guarantee a prescription, and a program can decline if it is not clinically suitable.

Are these programs for diabetes or for weight loss?

This trips up a lot of shoppers because the same molecules are sold under different brand names for different uses. Ozempic and Mounjaro are FDA-approved to treat type 2 diabetes.^[2][3] Wegovy and Zepbound are the same molecules (semaglutide and tirzepatide) approved specifically for chronic weight management in people who meet the BMI criteria above.^[4][5]

The online programs compared on this page are weight-management programs. They are not a substitute for diabetes care. If you have type 2 diabetes, tell the program and your regular doctor, since GLP-1 dosing and monitoring differ when the goal is blood-sugar control.

Common GLP-1 side effects

GLP-1 side effects are mostly gastrointestinal and tend to be worst when you first start or step up a dose. The most common are nausea, vomiting, diarrhea, constipation, and abdominal pain.^[1][2] Reputable programs reduce these by titrating, that is, starting at a low dose and increasing slowly over weeks rather than jumping to a full dose.

Less common but more serious risks reported with this drug class include pancreatitis, gallbladder problems, and low blood sugar when combined with certain diabetes medicines. These drugs also carry a boxed warning about thyroid C-cell tumors based on rodent studies, and they are not for people with a personal or family history of medullary thyroid carcinoma or MEN 2.^[1][2] Seek medical care for severe or persistent vomiting, severe abdominal pain, or signs of an allergic reaction.

Is compounded semaglutide or tirzepatide safe? How sourcing works

Many low-cost online programs prescribe compounded GLP-1s rather than the brand-name pen. Compounded drugs are mixed by pharmacies and are not individually reviewed or approved by the FDA the way Ozempic, Wegovy, Mounjaro, and Zepbound are.^[6] They come from two kinds of facilities: 503A pharmacies, which compound for an individual patient prescription, and 503B outsourcing facilities, which make larger batches under stricter manufacturing standards.^[6]

The FDA has flagged specific concerns with compounded GLP-1s, including dosing errors and the use of unapproved salt forms of the active ingredient.^[7] This does not mean every compounded product is unsafe, but it is why sourcing matters. When comparing programs, it is reasonable to ask which pharmacy or 503B facility they use, whether the product is third-party tested, and whether a licensed US clinician is prescribing it.

Will insurance cover an online GLP-1 program?

Coverage is the single biggest variable in real cost. Brand-name GLP-1s are often covered for type 2 diabetes but coverage for weight loss is inconsistent, and many plans require prior authorization (your clinician must justify the prescription to the insurer) or step therapy (you must try other options first). Because of that, most of the low monthly prices in the comparison above are for cash-pay compounded programs, which usually do not bill insurance at all. If you want to use insurance, a program that prescribes brand-name Wegovy or Zepbound and supports prior authorization will fit better than a cash-pay compounded plan, even though the sticker price looks higher.

Frequently asked questions

References

1. Collins L, Costello RA. Glucagon-Like Peptide-1 Receptor Agonists. StatPearls, NCBI Bookshelf.
2. Smith NK, et al. Semaglutide. StatPearls, NCBI Bookshelf.
3. Farzam K, Patel P. Tirzepatide. StatPearls, NCBI Bookshelf.
4. Prescription Medications to Treat Overweight and Obesity. NIDDK, National Institutes of Health.
5. FDA Approves New Medication for Chronic Weight Management (Zepbound). U.S. Food and Drug Administration.
6. Compounding and the FDA: Questions and Answers. U.S. Food and Drug Administration.
7. FDA's Concerns with Unapproved GLP-1 Drugs Used for Weight Loss. U.S. Food and Drug Administration.
8. About Obesity. Centers for Disease Control and Prevention.